Lupin (4QFY21): Positives in the price. Downgrade to ADD
We tweak our estimates by -3%/+4% for FY22/23e and revise the TP to INR1,220. Downgrade to ADD. Lupins 4Q sales/EBITDA was ~5%/9% below our...
144 Views
Gland Pharma IPO Trading - Squeezed Through, Now for the Real Test
Gland Pharma raised around US$900m in one of India’s largest IPOs in 2020. The company was established in 1978. KKR invested in 2014 and Fosun...
360 Views
Gland Pharma IPO - High on Growth but Low on Details
Gland Pharma aims to raise around US$900m in what would be one of India’s largest IPOs in 2020. Fosun Pharmaceutical bought a 74% stake in the...
443 Views
Sensex Rebalance Preview: Early Look
The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...
357 Views
COVID-19 : A Viral Threat to Pharma Supply Chain
Corona Virus shadows are glooming all over the world, and these fears have just begun. As a major highlight of 2020, the virus has conquered the...
416 Views